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A Case of Motor Neuron Disease 





Department of Emergency Medicine, Dankook University College of Medicine, Cheonan, Korea
Motor neuron disease encompasses a group of progressive neurologic disorders that destroy cells responsible for the 
control of essential muscles. The disorders are characterized by progressive weakness, muscle atrophy and fasciculation, 
spasticity, dysarthria, dysphagia, and respiratory compromise. A 66-year-old male presented to the emergency department 
with progressive dyspnea and, ultimately, respiratory failure. In spite of extensive cardiopulmonary evaluation, a cause 
could not be identiﬁ  ed except aging. After complete history taking, physical and neurologic examination, motor neuron 
disease was suspected at last. Thus, elderly patients with dyspnea in the emergency department could have hidden 
diseases beyond the normal aging process.
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muscle wasting and weakness.
1) Although symptoms may 
originate in one region, they will typically spread to involve other 
areas. Aft  er several years, most patients require help with activities 
of daily living. Weakness of respiratory muscles is common and 
is the presenting symptom in rare cases in ALS. Early in ALS, 
individuals complain of dyspnea with exertion and frequently 
sigh at rest. With disease progression, dyspnea at rest, inability to 
sleep in a supine position, sleep apnea, and morning headaches 
are present.
1) In the elderly, other more common diagnoses 
associated with the aging process, such as heart failure, aspiration 
pneumonia, and dementia, can delay the diagnosis of MND. 
We present a case report involving a farmer who visited the 
emergency department due to dyspnea.
CASE REPORT
A previously healthy, 66-year-old male patient presented to 
the emergency department (ED) for evaluation of progressive 
dyspnea, which had begun 3 months prior to presentation. His 
family and past medical history were not remarkable except for 
INTRODUCTION
Motor neuron disease (MND) is a heterogenous group of 
disorders those selectively aff  ect upper or lower motor neurons, 
or both. Sporadic amyotrophic lateral sclerosis (ALS) accounts 
for approximately 80% of all cases of acquired motor neuron 
disease, whereas the remaining 20% of patients have either only 
lower motor neuron signs or a familial form of ALS (FALS). Th  e 
80% of patients who have sporadic ALS present with spasticity, 
hyperreflexia, and Babinski’s sign in the setting of progressive  Hyun Soo Park: Motor Neuron Disease Presenting as Dyspnea
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benign prostatic hyperplasia. He was a non-smoker and denied 
alcohol use. Th   e patient denied any chest pain, rhinorrhea, cough, 
sputum production, or fever. The dyspnea was aggravated by 
exercise and relieved with rest. On examination, he was alert, but 
appeared thin, scaled and pale. His vital signs included a blood 
pressure of 143/73 mm Hg, heart rate of 84/min, respiratory rate 
of 18/min, temperature of 36.4
oC, and an oxygen saturation of 
89% measured by pulse oximeter. The conjunctivae were pink. 
The lungs were clear to auscultation without wheezes, rales, or 
rhonchi. Th   ere was no abnormal heart sound or pitt  ing edema at 
the ankles. Th   e abdomen was fl  at and had normal bowel sound.
Th   e initial laboratory evaluation showed an arterial blood gas 
of pH 7.347, PCO2 66.6 mm Hg, PO2 63.3 mm Hg, and HCO
3- 
31.3 mmol/L. Point-of-care testing included creatine kinase 133 
IU/L, creatine kinase-MB 6.8 ng/mL, troponin-I 0.01 ng/mL, 
B-type natriuretic peptide 12, and D-dimer 0.03. Blood chemistry 
analysis and complete blood count were normal. Influenza 
antigen test was negative. A chest radiograph showed atelectasis 
in the right upper lung field (Figure 1). Electrocardiography 
revealed right atrial enlargement and left   ventricular hypertrophy 
with sinus rhythm (Figure 2).
Despite oxygen treatment with an 8-liter oxygen mask 
with reserved bag, the dyspnea became worse, and the oxygen 
saturation dropped to 86% aft  er 3 hours. Computed tomography 
of the chest identified bronchiectasis in right upper lung field 
associated with bronchopneumonia (Figure 3). However, his 
symptoms were not entirely explained by this fi  nding. A bedside 
echocardiogram revealed good left   ventricular function (ejection 
fraction 56%) and normal heart size without wall motion 
abnormality nor valvular problems.
The patient’s history was reviewed, and the physical 
examination was repeated to look for additional information. 
The patient reported a 10 kg weight loss over the last year and 
had been bedridden for generalized weakness. The neurologic 
examination disclosed dysarthria, mild bilateral lower extremity 
weakness, and calf muscle atrophy. The dyspnea progressed to 
respiratory failure after 6 hours from the time of presentation 
in the emergency department, and intubation was required. 
Further investigations with nerve conduction study and 
electromyography demonstrated widespread denervation 
without any electrophysiologic abnormal findings of peripheral 
neuropathy. Finally, the patient was discharged with tracheostomy 
and home ventilator after several weeks’ antibiotics treatment, 
and followed up via out-patient department.
DISCUSSION
MND refers to a group of diseases that affect the cells that 
control voluntary muscle activity. In the United States, MND 
is more commonly referred to as ALS or Lou Gehrig’s disease 
(to avoid confusion, the annual scientific research conference 
dedicated to the study of MND is called the International ALS/
MND Symposium). ALS/MND refers to a specific subset of 
pathologically identical diseases. Forms of motor neuron disease 
Figure 1. Chest X-ray. Right upper lung bronchopneumonia (arrow).
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include FALS, spinal muscular atrophy, bulbospinal muscular 
atrophy, anterior poliomyelitis, sporadic ALS, and primary lateral 
sclerosis.
1)
Currently, no cures exist for MND. Th   e only drug that aff  ects 
the course of the disease is riluzole, which blocks the effect of 
the neurotransmitter glutamate. Riluzole generally extends 
the lifespan of an MND patient by a few months.
2) The lack of 
effective medications to slow the progression of MND does 
not imply that patients cannot be medically treated. Treatment 
focuses on the relief of symptoms associated with the disease 
as this case. A variety of health care professionals, including 
neurologists, speech-language pathologists, physical therapists, 
occupational therapists, dieticians, respiratory therapists, 
social workers, palliative care specialists, specialist nurses, and 
psychologists, are usually involved in the care of MND patients.
1)
The incidence of MND is approximately 1 to 5 in 100,000 
people, and men experience a slightly higher incidence than 
women. Symptoms usually present between the ages of 50 and 
70 years, and include progressive weakness, muscle wasting, 
muscle fasciculation, spasticity or stiffness in the arms and 
legs, and overactive tendon reflexes. Neurologic examination 
identifies specific signs associated with upper and lower motor 
neuron degeneration. Signs of upper motor neuron damage 
include spasticity and brisk refl  exes. Pathologic refl  exes, including 
Hoffmann’s sign in the fingers and the Babinski sign, are 
frequently seen. Signs of lower motor neuron damage include 
weakness, fasciculations, and muscle atrophy. These signs can 
occur in any muscle group, including the arms, legs, torso, and 
bulbar region.
1) In the vast majority of patients, limb weakness 
will occur within 1 to 2 years of the onset of bulbar symptoms.
3) 
Swallowing difficulties and diaphragmatic weakness are usually 
late features.
4)
Figure 3. Enhanced chest computed tomography showed bronchiectasis with mucous plugging in right upper lobe. Otherwise, there was 
no remarkable ﬁ  nding. Hyun Soo Park: Motor Neuron Disease Presenting as Dyspnea
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Approximately 5% of cases with MND present with 
respiratory weakness without significant limb or bulbar 
symptoms.
4,5) These patients present with symptoms of type 2 
respiratory failure or nocturnal hypoventilation with dyspnea, 
orthopnea, disturbed sleep, morning headaches, and excessive day 
time somnolence.
6) Yagyu et al.
7) and Czaplinski et al.
8) reported 
patients who had the motor neuron disease with respiratory 
failure as a primary manifestation, and visited ED. Similarly, 
our patient visited ED with respiratory failure as a presenting 
symptom, however motor weakness was developed before the 
respiratory symptom that was neglected and considered a part 
of the aging process by his family. Th   e physicians in ED regarded 
the dyspnea as a manifestation of pneumonia, and the pathologic 
motor weakness as a general weakness from infection at fi  rst.
In conclusion, primary care physicians are often quick 
to conclude that motor power has weakened due to aging, 
only after usual history taking without cautious physical and 
neurologic examination. However, physicians who encounter 
patients with dyspnea in ED have to rule out pulmonary and 
cardiac dysfunction above all. If the clinical feature could not be 
explained, a diff  erential diagnosis should be maintained, including 
neurologic disorders, which can frequently be overlooked in the 
elderly.
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